Home > Income Statement > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Revenue

    Back to Income Statement
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results

GUJARAT THEMIS BIOSYN Last 5 Year Revenue History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹170 Cr₹148 Cr₹115 Cr₹91 Cr₹85 Cr

What is the latest Revenue of GUJARAT THEMIS BIOSYN ?

The latest Revenue ratio of GUJARAT THEMIS BIOSYN is ₹170 Cr based on Mar2024 Standalone results.
Year Revenue
Mar2024₹170 Cr
Mar2023₹148 Cr
Mar2022₹115 Cr
Mar2021₹91 Cr
Mar2020₹85 Cr

How is Revenue of GUJARAT THEMIS BIOSYN Trending?

Years Revenue % Change
Mar2024 ₹170 Cr
14.45
Mar2023 ₹148 Cr
29.19
Mar2022 ₹115 Cr
26.82
Mar2021 ₹91 Cr
6.39
Mar2020 ₹85 Cr -

Compare Revenue of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹4,045.5 Cr 7.5% 10.1% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,091.0 Cr 2.3% 3.2% 9.5% Stock Analytics
DIVIS LABORATORIES ₹181,302.0 Cr -0.2% 4.5% 49.6% Stock Analytics
CIPLA ₹119,038.0 Cr -0.2% -2% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹117,170.0 Cr 3.7% 6.5% 16.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,061.0 Cr -0% -4.6% -6.2% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

7.5%

10.1%

10.1%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses